scholarly journals Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

1993 ◽  
Vol 37 (8) ◽  
pp. 1655-1658 ◽  
Author(s):  
H C Meissner ◽  
D R Fulton ◽  
J R Groothuis ◽  
R L Geggel ◽  
G R Marx ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
High Risk ◽  
Immune Globulin ◽  
Virus Disease ◽  
Controlled Trial ◽  
Intravenous Immune Globulin ◽  
Respiratory Syncytial Virus Disease ◽  
Syncytial Virus ◽  
High Risk Infants

scholarly journals Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants

2014 ◽  
Vol 10 (10) ◽  
pp. 2789-2794 ◽  
Author(s):  
Michael L Forbes ◽  
Veena R Kumar ◽  
Ram Yogev ◽  
Xionghua Wu ◽  
Gabriel J Robbie ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
High Risk ◽  
Virus Disease ◽  
Respiratory Syncytial Virus Disease ◽  
Syncytial Virus ◽  
High Risk Infants

Intravenous Palivizumab and Ribavirin Combination for Respiratory Syncytial Virus Disease in High-Risk Pediatric Patients

2007 ◽  
Vol 26 (12) ◽  
pp. 1089-1093 ◽  
Author(s):  
Susana Chávez-Bueno ◽  
Asunción Mejías ◽  
Ruth A. Merryman ◽  
Naveed Ahmad ◽  
Hasan S. Jafri ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
High Risk ◽  
Pediatric Patients ◽  
Virus Disease ◽  
Respiratory Syncytial Virus Disease ◽  
Syncytial Virus
Sign in / Sign up

Export Citation Format

Share Document